424 related articles for article (PubMed ID: 18448859)
1. Omega-3/omega-6 fatty acids for attention deficit hyperactivity disorder: a randomized placebo-controlled trial in children and adolescents.
Johnson M; Ostlund S; Fransson G; Kadesjö B; Gillberg C
J Atten Disord; 2009 Mar; 12(5):394-401. PubMed ID: 18448859
[TBL] [Abstract][Full Text] [Related]
2. The Oxford-Durham study: a randomized, controlled trial of dietary supplementation with fatty acids in children with developmental coordination disorder.
Richardson AJ; Montgomery P
Pediatrics; 2005 May; 115(5):1360-6. PubMed ID: 15867048
[TBL] [Abstract][Full Text] [Related]
3. [Omega-3 and omega-6 fatty acids in the treatment of children and adolescents with ADHD].
Aben A; Danckaerts M
Tijdschr Psychiatr; 2010; 52(2):89-97. PubMed ID: 20146180
[TBL] [Abstract][Full Text] [Related]
4. Modafinil improves symptoms of attention-deficit/hyperactivity disorder across subtypes in children and adolescents.
Biederman J; Pliszka SR
J Pediatr; 2008 Mar; 152(3):394-9. PubMed ID: 18280848
[TBL] [Abstract][Full Text] [Related]
5. Fatty acids in ADHD: plasma profiles in a placebo-controlled study of Omega 3/6 fatty acids in children and adolescents.
Johnson M; Månsson JE; Ostlund S; Fransson G; Areskoug B; Hjalmarsson K; Landgren M; Kadesjö B; Gillberg C
Atten Defic Hyperact Disord; 2012 Dec; 4(4):199-204. PubMed ID: 22753087
[TBL] [Abstract][Full Text] [Related]
6. A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder.
Biederman J; Melmed RD; Patel A; McBurnett K; Konow J; Lyne A; Scherer N;
Pediatrics; 2008 Jan; 121(1):e73-84. PubMed ID: 18166547
[TBL] [Abstract][Full Text] [Related]
7. Modafinil in children and adolescents with attention-deficit/hyperactivity disorder: a preliminary 8-week, open-label study.
Boellner SW; Earl CQ; Arora S
Curr Med Res Opin; 2006 Dec; 22(12):2457-65. PubMed ID: 17257460
[TBL] [Abstract][Full Text] [Related]
8. Atomoxetine hydrochloride in the treatment of children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: A placebo-controlled Italian study.
Dell'Agnello G; Maschietto D; Bravaccio C; Calamoneri F; Masi G; Curatolo P; Besana D; Mancini F; Rossi A; Poole L; Escobar R; Zuddas A;
Eur Neuropsychopharmacol; 2009 Nov; 19(11):822-34. PubMed ID: 19716683
[TBL] [Abstract][Full Text] [Related]
9. Omega-3 fatty acids in ADHD and related neurodevelopmental disorders.
Richardson AJ
Int Rev Psychiatry; 2006 Apr; 18(2):155-72. PubMed ID: 16777670
[TBL] [Abstract][Full Text] [Related]
10. Atomoxetine treatment in adults with attention-deficit/hyperactivity disorder and comorbid social anxiety disorder.
Adler LA; Liebowitz M; Kronenberger W; Qiao M; Rubin R; Hollandbeck M; Deldar A; Schuh K; Durell T
Depress Anxiety; 2009; 26(3):212-21. PubMed ID: 19194995
[TBL] [Abstract][Full Text] [Related]
11. A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit/hyperactivity disorder.
Voigt RG; Llorente AM; Jensen CL; Fraley JK; Berretta MC; Heird WC
J Pediatr; 2001 Aug; 139(2):189-96. PubMed ID: 11487742
[TBL] [Abstract][Full Text] [Related]
12. Effect of supplementation with polyunsaturated fatty acids and micronutrients on learning and behavior problems associated with child ADHD.
Sinn N; Bryan J
J Dev Behav Pediatr; 2007 Apr; 28(2):82-91. PubMed ID: 17435458
[TBL] [Abstract][Full Text] [Related]
13. Symptoms of attention-deficit/hyperactivity disorder following traumatic brain injury in children.
Levin H; Hanten G; Max J; Li X; Swank P; Ewing-Cobbs L; Dennis M; Menefee DS; Schachar R
J Dev Behav Pediatr; 2007 Apr; 28(2):108-18. PubMed ID: 17435461
[TBL] [Abstract][Full Text] [Related]
14. Omega-3 fatty acids supplementation in children with autism: a double-blind randomized, placebo-controlled pilot study.
Amminger GP; Berger GE; Schäfer MR; Klier C; Friedrich MH; Feucht M
Biol Psychiatry; 2007 Feb; 61(4):551-3. PubMed ID: 16920077
[TBL] [Abstract][Full Text] [Related]
15. A randomized, double-blind and placebo-controlled trial of modafinil in children and adolescents with attention deficit and hyperactivity disorder.
Kahbazi M; Ghoreishi A; Rahiminejad F; Mohammadi MR; Kamalipour A; Akhondzadeh S
Psychiatry Res; 2009 Aug; 168(3):234-7. PubMed ID: 19439364
[TBL] [Abstract][Full Text] [Related]
16. Executive functions: performance-based measures and the behavior rating inventory of executive function (BRIEF) in adolescents with attention deficit/hyperactivity disorder (ADHD).
Toplak ME; Bucciarelli SM; Jain U; Tannock R
Child Neuropsychol; 2009 Jan; 15(1):53-72. PubMed ID: 18608232
[TBL] [Abstract][Full Text] [Related]
17. [Attention deficit/hyperactivity disorder: burden of the disease according to subtypes in recently diagnosed children].
Escobar R; Hervas A; Soutullo C; Mardomingo MJ; Uruñuela A; Gilaberte I
Actas Esp Psiquiatr; 2008; 36(5):285-94. PubMed ID: 18830848
[TBL] [Abstract][Full Text] [Related]
18. Neuropsychiatric and neurodevelopmental outcome of children at age 6 and 7 years who screened positive for language problems at 30 months.
Miniscalco C; Nygren G; Hagberg B; Kadesjö B; Gillberg C
Dev Med Child Neurol; 2006 May; 48(5):361-6. PubMed ID: 16608544
[TBL] [Abstract][Full Text] [Related]
19. Total red blood cell concentrations of omega-3 fatty acids are associated with emotion-elicited neural activity in adolescent boys with attention-deficit hyperactivity disorder.
Gow RV; Matsudaira T; Taylor E; Rubia K; Crawford M; Ghebremeskel K; Ibrahimovic A; Vallée-Tourangeau F; Williams LM; Sumich A
Prostaglandins Leukot Essent Fatty Acids; 2009; 80(2-3):151-6. PubMed ID: 19230637
[TBL] [Abstract][Full Text] [Related]
20. Attention deficit/hyperactivity disorder in children and adolescents with autism spectrum disorder: symptom or syndrome?
Sinzig J; Walter D; Doepfner M
J Atten Disord; 2009 Sep; 13(2):117-26. PubMed ID: 19380514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
